Evidence map›Paper›PMID 34299638›Full record

ReviewMolecules (Basel, Switzerland)2021

Current Status of Endoplasmic Reticulum Stress in Type II Diabetes.

Sagir Mustapha, Mustapha Mohammed, Ahmad Khusairi Azemi, Abubakar Ibrahim Jatau, Aishatu Shehu, Lukman Mustapha, Ibrahim Muazzamu Aliyu, Rabi'u Nuhu Danraka, Abdulbasit Amin, Auwal Adam Bala and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Zingerone alleviates diabetic nephropathy by interrupting the ER stress-inflammation-apoptosis cascade in streptozotocin-induced diabetic mice.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Aldolase-regulated G3BP1/2The EMBO journal · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Beyond Glucose: The Dual Assault of Oxidative and ER Stress in Diabetic Disorders.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Sagir MustaphaDepartment of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 16150, Kelantan, Malaysia.ORCID 0000-0003-4185-1680
Mustapha MohammedSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Pulau Pinang, Malaysia.ORCID 0000-0002-5021-1610
Ahmad Khusairi AzemiDepartment of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 16150, Kelantan, Malaysia.ORCID 0000-0002-1632-9754
Abubakar Ibrahim JatauSchool of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia.ORCID 0000-0001-9336-6877
Aishatu ShehuDepartment of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria 810107, Kaduna, Nigeria.
Lukman MustaphaDepartment of Pharmaceutical and Medicinal Chemistry, Kaduna State University, Kaduna 800241, Kaduna, Nigeria.ORCID 0000-0002-8208-8063
Ibrahim Muazzamu AliyuDepartment of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria 810107, Kaduna, Nigeria.
Rabi'u Nuhu DanrakaDepartment of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria 810107, Kaduna, Nigeria.
Abdulbasit AminDepartment of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin 240103, Kwara, Nigeria.
Auwal Adam BalaDepartment of Pharmacology, College of Medicine and Health Sciences, Federal University Dutse, Dutse 720281, Jigawa, Nigeria.ORCID 0000-0003-0402-9639
Wan Amir Nizam Wan AhmadBiomedicine Programme, School of Health Sciences, Universiti Sains Malaysia, Kota Bharu 16150, Kelantan, Malaysia.ORCID 0000-0002-0771-2559
Aida Hanum Ghulam RasoolDepartment of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 16150, Kelantan, Malaysia.
Mohd Rais MustafaDepartment of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
Siti Safiah MokhtarDepartment of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 16150, Kelantan, Malaysia.
Ahmadu Bello University · NGHospital Universiti Sains Malaysia · MYFederal University DutseKaduna State University · NGUniversity of Ilorin · NGUniversity of Malaya · MYUniversity of Tasmania · AU

Funding

Ministry of Higher Education, Malaysia 203/ PPSP/6171215
6 · The paper itself

Abstract

The endoplasmic reticulum (ER) plays a multifunctional role in lipid biosynthesis, calcium storage, protein folding, and processing. Thus, maintaining ER homeostasis is essential for cellular functions. Several pathophysiological conditions and pharmacological agents are known to disrupt ER homeostasis, thereby, causing ER stress. The cells react to ER stress by initiating an adaptive signaling process called the unfolded protein response (UPR). However, the ER initiates death signaling pathways when ER stress persists. ER stress is linked to several diseases, such as cancer, obesity, and diabetes. Thus, its regulation can provide possible therapeutic targets for these. Current evidence suggests that chronic hyperglycemia and hyperlipidemia linked to type II diabetes disrupt ER homeostasis, thereby, resulting in irreversible UPR activation and cell death. Despite progress in understanding the pathophysiology of the UPR and ER stress, to date, the mechanisms of ER stress in relation to type II diabetes remain unclear. This review provides up-to-date information regarding the UPR, ER stress mechanisms, insulin dysfunction, oxidative stress, and the therapeutic potential of targeting specific ER stress pathways.

Indexed as

Endoplasmic Reticulum StressOxidative StressSignal TransductionAnimalsDiabetes Mellitus, Type 2HumansHyperglycemiaHyperlipidemiasNeoplasmsObesityapoptosisendoplasmic reticulumendoplasmic reticulum stresshomeostasistype II diabetesunfolded protein response

Identifiers

PMID34299638
PMCPMC8307902
OpenAlexW3169942843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.